Bessent Touts AI Dialogue With China And ‘Notification Mechanism’ For Incidents
Bessent met with Chinese Vice Premier He Lifeng in New York on Sunday ahead of President Xi Jinping’s visit to the U.S. later this week.
Economy
-
-
Sensex jumps 400 points, Nifty nears 23,400 as oil prices cool down despite Middle East tensions. What lies ahead?
Indian equities gained in early trade as lower crude prices lifted sentiment, with Sensex rising 0.6% and Nifty 0.2%. Analysts expect volatility to persist amid geopolitical risks, elevated yields and sectoral rotation.
-
HEG shares rally 5% after receiving Rs 217.56 crore order from Indus Towers for lithium-ion battery banks
HEG shares rose sharply on Monday after subsidiary Replus Engitech received a Rs 217.56 crore order from Indus Towers for lithium-ion battery banks. The order is to be executed by March 31, 2027. The development comes as HEG progresses with its demerger into separate graphite electrodes and advanced materials businesses.
-
OFSS shares tumble 7%; Wipro, Coforge, Infosys shares down up to 2%. Why are IT stocks under pressure today?
Shares of OFSS fell over 7% while top IT stocks including Infosys, Wipro, and Coforge dropped up to 2% on Monday. The drag comes following reports of Oracle’s $18 billion data centre debt pressure and US President Donald Trump extending the $100,000 H-1B visa fee by another year.
-
Lenskart shares drop 3% after 3 crore shares change hands in block deal; Platinum Jasmine likely seller
Lenskart Solutions shares fell over 3% to Rs 683 after a massive block deal worth Rs 2,047 crore saw 3.53 crore shares change hands. Platinum Jasmine is likely the seller offloading a 1.7% stake. Despite today’s drop, the stock remains up over 58% in 2026.
-
JSW Cement shares gain 2% after Motilal Oswal upgrades stock to Buy. Check target price
JSW Cement shares gained nearly 2% after Motilal Oswal upgraded the stock to Buy from Neutral, citing strong volume growth, North India expansion, cost efficiencies and an improving medium-term growth outlook.
-
Specialised Therapeutics to commercialize Incyte’s Opzelura in Australia
-
Pfizer to share higher overseas drug revenue with U.S. under new HHS contract: report
-
Facebook, Instagram recover after brief outage hits users in U.S. and other markets
-
US coffee chain Starbucks plans tech centre in India, source says